Benzinga's Top Pre-Market NASDAQ Losers (CREE, DEPO, WSB, IBCA)

Cree Inc CREE dipped 15.64% to $52.90 in the pre-market session. CREE issued weaker-than-expected Q3 profit and revenue projections. Depomed Inc DEPO fell 12.46% to $5.76 in the pre-market session. DEPO reported that it is looking to resolve dispute with Abbott Laboratories ABT over a disagreement about the launch of a pain drug candidate. WSB Holdings Inc WSB moved down 8.62% to $2.65 in the pre-market session. WSB's trailing-twelve-month profit margin is -43.08%. Intervest Bancshares Corp IBCA dropped 6.46% to $2.75 in the pre-market trading. IBCA reported its Q4 net earnings at $0.02 per share, down from $0.04 per share, in the year-ago quarter. Read more from Benzinga's Markets.